SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix (OCUL) is heavily trending amid high anticipation for imminent topline data from its Phase 3 superiority trial of Axpaxli in wet AMD, with the community widely expecting positive results to drive significant upside. Adding to the bullish sentiment, speculation of a sweetened Sanofi buyout offer, following a rejected previous bid, is fueling active discussion around potential acquisition prices and a forthcoming short squeeze.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Compass Pathways is garnering significant attention following accelerated commercial launch plans by 9-12 months and FDA clearance for late-stage PTSD trials, sparking community discussion about its potential as a first-mover in the evolving psychedelic therapeutics sector.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

A major acquisition offer for Zim Integrated Shipping Services is driving intense conversation, with many anticipating a significant short squeeze, while others debate the deal's valuation and the crucial factor of Israeli government and worker approval.

BitGo Holdings, Inc. provides cryptocurrency custody solutions. It offers self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service. The company was founded by Michael Belshe in 2013 and is headquartered in Palo Alto, CA.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo is trending as multiple investment banks initiate 'Buy' ratings, highlighting its institutional digital asset custody and prime brokerage model as a resilient 'monopoly' poised for significant growth. The community is actively debating its perceived undervaluation and potential for a short squeeze amidst concerns over initial post-IPO volatility and broader crypto market sentiment.

Builders FirstSource, Inc. engages in the supply and manufacture of building materials, manufactured components, and construction services to professional homebuilders, sub-contractors, remodelers, and consumers. Its products include factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The company was founded by Kevin P. O'Meara, Donald F. McAleenan and John D. Roach in March 1998 and is headquartered in Irving, TX.

Builders Firstsource Inc

Builders FirstSource is trending as its recent adjusted EPS miss and conservative outlook spark intense community debate over financial health and debt strategy within a volatile housing sector. This sentiment is further complicated by ongoing acquisition speculation and a substantial insider share purchase, leaving investors divided on the company's future trajectory.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following conditional EU marketing authorization for ANKTIVA and productive high-level discussions in Saudi Arabia hinting at significant investments and broad approvals for its cancer therapies, generating community excitement around a potential short squeeze and a major global shift in biotech innovation.

CNH Industrial NV is an equipment and services company, which develops, manufactures and sells specialized machines and services for the farming and construction industries, and supplies replacement parts and accessories. It operates through the following operating segments: Agriculture, Construction, and Financial Services. The Agriculture segment designs, manufactures, and distributes a full line of farm machinery and implements, including two-wheel and four-wheel drive tractors, crawler tractors, combines, grape and sugar cane harvesters, hay and forage equipment, planting and seeding equipment, soil preparation and cultivation implements and material handling equipment. The Construction segment comprises of a full line of construction equipment including excavators, crawler dozers, graders, wheel loaders, backhoe loaders, skid steer loaders, and compact track loaders. The Financial Services segment offers retail note and lease financing to end-use customers for the purchase of new and used agricultural and construction equipment and components. The company was founded in 1866 and is headquartered in London, the United Kingdom.

CNH Industrial NV

CNH Industrial is seeing increased investor discussion after a recent earnings beat and amid activist investor interest, with the community debating its potential as an undervalued cyclical play in the challenging but evolving agriculture and construction equipment sectors.

Louisiana-Pacific Corp. engages in the provision of building solutions. It operates through the following segments: Siding, Oriented Strand Board (OSB), LP South America (LPSA), and Other. The Siding segment offers engineered wood siding trim and fascia, including LP SmartSide Trim and Siding, LP SmartSide ExpertFinish Trim and Siding, LP BuilderSeries Lap Siding, and LP Outdoor Building Solutions. The OSB segment includes structural panel products for roof decking, sidewall sheathing, and floor underlayment. The LPSA segment manufactures and distributes LP OSB structural panel and siding products in South America and certain export markets. The Other segment refers to off-site framing operations, remaining timber and timberlands, and other minor products, services, and closed operations. The company was founded in 1972 and is headquartered in Nashville, TN.

Louisiana-Pacific Corp.

LP Building Solutions is trending after its Q4 earnings report, which highlighted an adjusted EPS beat against a revenue miss and negative GAAP EPS, alongside a cautious Q1 outlook predicting a decline in siding sales and an OSB segment loss. The community is keenly observing if the strength in Siding can continue to counterbalance weakness in the OSB segment amidst persistent housing market volatility and broader sector concerns.

Allegion Plc engages in the provision of security products and solutions that keep people safe, secure, and productive. It operates through the Allegion Americas and Allegion International segments. The Allegion Americas segment offers security products, services, and solutions throughout North America. The Allegion International segment refers to security products, services, and solutions primarily throughout Europe, Asia and Oceania. The company was founded on May 9, 2013 and is headquartered in Dublin, Ireland.

Allegion plc

Allegion (ALLE) is trending following its recent strong Q4 earnings report and positive FY26 guidance, showcasing robust revenue growth and profitability in its security and safety solutions segment. The community is actively discussing the company's consistent performance, strategic acquisitions, and steady demand from non-residential markets, with many evaluating its growth trajectory and ideal entry points.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending as a major institutional initiation highlights its leadership in growing defense areas like drones and counter-drone technology, with community discussion amplified by recent proposals for significantly increased military spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The company’s FDA-cleared INSPIRA ART100 system is approved for cardiopulmonary bypass in the U.S.&nbsp;</li><li>With this step, ART100 moves from regulatory clearance to active commercial availability, the company said.</li><li>Earlier, Inspira announced a non-binding term sheet for a proposed two-part deal to acquire an advanced liquid biopsy diagnostics business</li></ul>Shares of Inspira Technologies OXY (IINN) popped over 28% in pre-market trading on Monday after Israel’s largest health services provider approved the procurement of its FDA-cleared ART100 platform.<a href="https://stocktwits.com/symbol/IINN">IINN shares</a> gave up premarket gains and fell around 3% after the opening bell.&nbsp;The company secured approval from Clalit Health Services’ Medical Equipment Committee, allowing its INSPIRA ART100 system to be immediately procured and deployed across a healthcare network serving roughly 4.9 million members.<h2 class="st-heading-2">ART100 Regulatory Clearance</h2>With this step, ART100 moves from regulatory clearance to active commercial availability, marking a significant growth opportunity for Inspira and strong clinical validation.“By securing this approval, we are laying the foundation for potentially long-term, high-quality revenue. This validation from a world-class, data-driven health ecosystem serves as a powerful reference case as we accelerate our commercialization efforts in the U.S. and other global markets,” said Dagi Ben-Noon, CEO of Inspira Technologies.The company’s FDA-cleared INSPIRA ART100 system is approved for cardiopulmonary bypass in the U.S. and for (Extracorporeal Membrane Oxygenation) ECMO procedures outside the U.S.<h2 class="st-heading-2">Top U.S. Medical Center Clears ART100&nbsp;</h2>In January, Inspira Technologies’ ART100 system completed clinical evaluation at a top U.S. academic medical centre and moved into the budgeted procurement stage. The system successfully treated about 30 patients across surgeries, transplants, and other critical procedures, leading to its adoption into routine clinical workflows.&nbsp;With the evaluation phase now closed, the hospital has begun an internal process to purchase multiple ART100 units, pending final budget approval.Earlier, Inspira announced a non-binding term sheet for a proposed two-part deal to acquire an advanced liquid biopsy diagnostics business. The transaction also includes a planned $15 million strategic equity investment.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a day earlier, amid ‘extremely high’ message volumes.The stock has shed around 25% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

Why Did IINN Stock Surge 28% In Pre-Market Today?

The company won approval from Clalit Health Services to deploy its INSPIRA ART100 system across a network of around 4.9 million members.

Equity

All You Need to Know About Inspira Technologies OXY (IINN) Rating Upgrade to Buy

Inspira Technologies OXY (IINN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Inspira Technologies OXY B.H.N. (IINN) on Friday announced that it has received U.S. Patent approval for the core technology of its ART500 device.The firm stated that the device is key to penetrating the $20 billion estimated market for advanced respiratory support. The newly received patent provides protection at least until the year 2043, covering key claims related to the ART500’s functionality, design, and clinical applications.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/IINN">IINN stock</a> stayed within ‘extremely bullish’ territory over the past 24 hours, while message volume remained at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:577/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_22_at_2_07_05_PM_png_792c0ec45d.webp" alt="IINN's Sentiment Meter and Message Volume as of 2:07 p.m. ET on Aug. 22, 2025 | Source: Stocktwits" width="577" height="61"><figcaption>IINN's Sentiment Meter and Message Volume as of 2:07 p.m. ET on Aug. 22, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user said that they are loading up on the shares of the company.<stembedurl>https://stocktwits.com/VSWeWork/message/626246424</stembedurl>Another, however, sounded disappointed at the stock’s performance.<stembedurl>https://stocktwits.com/Kyavic77/message/626229410</stembedurl>The ART500 system is designed to provide extracorporeal oxygenation at low flow rates while maintaining patient safety and treatment efficiency. According to the firm, this targets a patient population that requires respiratory support but may not be sick enough for traditional, high-flow ECMO systems.Inspira CEO Dagi Ben-Noon <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/08/22/3137823/0/en/Inspira-Receives-U-S-Patent-Approval-for-the-ART500-Core-Technology-Key-Patent-Positions-the-Company-to-Dominate-20-Billion-Estimated-Market.html">said</a> that the patent has profound business implications for the company. “While our ART100 system is already generating commercial momentum, this move fortifies our future and gives us the clear runway…,” he said.Earlier this month, Inspira <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/08/19/3135699/0/en/Inspira-Secures-27-Million-Government-Binding-Purchase-Order-for-ART100-Systems-with-Full-Payment-in-2025.html">said</a> that a national ministry of health in Africa has placed a $27 million binding purchase order for its ART100 systems. The purchase order provides for full contractual payment scheduled for completion during 2025.IINN stock is up by 17% this year and by about 9% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/gary-black-believes-these-are-five-things-that-could-initiate-tesla-rally/chsZeukRdKP">Gary Black Believes These Are The Five Things That Could Initiate A Tesla Rally</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Global stock market chart and trading board - stock photo

Inspira Technologies Receives US Patent Clearance For Core Technology Of Its ART500 Device: Retail Loads Up On The Stock 

The newly received patent provides protection at least until the year 2043, covering key claims related to the ART500 device’s functionality, design, and clinical applications.

Inspira Technologies Oxy B.H.N. Ltd. is a specialty medical device company, which engages in research, development, manufacturing, and marketing of proprietary life support technology with a vision to supersede traditional mechanical ventilators, or Mechanical Ventilation, which is the standard of care today for the treatment of acute respiratory failure. The company was founded by Dagi Shahar Ben Noon, Joe Hayon, and Udi Nussinovitch in July 2017 and is headquartered in Raanana, Israel.

Inspira Technologies Oxy B.H.N. Ltd

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$0.5889
Prev Close	$0.589
Open	$0.57
Dividend Yield	0.00%
50-Day Moving Average	$0.8933
Beta	0.99
Avg. Volume	194,270.30
PE Ratio	-1.28

52-Week High	$1.65
52-Week Low	$0.4026
Market Capitalization	$24.19M
EPS (Annual)	-$0.597
Price to Book	13.20
Revenue Per Employee	$0.00

IINN
Inspira Technologies Oxy B.H.N. Ltd

Feed

News

Sentiment

Fundamentals

Info

Latest IINN News

IINNInspira Technologies Oxy B.H.N. Ltd